Labshake search
Citations for R&D Systems :
601 - 650 of 1327 citations for Methyl 3 2 morpholin 4 ylethoxy benzoate since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2024Quote: ... which was supplemented with 3 ng/mL human activin A (R&D Systems, Inc., Minneapolis, MN, USA), 1 ng/mL human bone morphogenetic protein 4 (Bmp4 ...
-
bioRxiv - Immunology 2023Quote: ... or with 10 µl biotinylated irrelevant antigen (3 nM final concentration; R&D Systems cat# AVI10538-050) for 20 minutes at room temperature in 96 half area white microplates (Corning cat# CLS3693) ...
-
bioRxiv - Microbiology 2023Quote: ... coli were made from an overnight agar culture and incubated with 3 mM HMGB1(R&D systems) diluted with protein block buffer (Dako ...
-
bioRxiv - Cell Biology 2023Quote: Immunohistochemistry was performed with the following antibodies: Cleaved Caspase 3 (rabbit, R&D Systems, MAB835, 1:100), Hopx (mouse ...
-
bioRxiv - Bioengineering 2024Quote: ... The FL5.12 cell culture media was also supplemented with 100 ng/ml IL-3 (R&D Systems). L1210 cells were obtained from ATCC ...
-
bioRxiv - Cancer Biology 2024Quote: ... The following primary antibodies were used: rabbit anti active caspase 3 (1:200; R&D Systems AF835), and rabbit anti-Ki67 (1:5000 ...
-
bioRxiv - Molecular Biology 2024Quote: ... cells were pre-incubated in 50µM of a specific caspase-3 (Z-DEVD-FMK, R&D Systems) or caspase-8 inhibitor (Z-IETD-FMK ...
-
RORγt-dependent antigen-presenting cells direct regulatory T cell-mediated tolerance to food antigenbioRxiv - Immunology 2024Quote: ... cells were stimulated ex vivo for 3 h with IL-23 (10 ng/mL; R&D systems) and GolgiStop (BD Biosciences ...
-
bioRxiv - Immunology 2023Quote: ... Subsequently the cells were rested and expanded in kool aid complete media for 2 days supplemented with 100 U/mL recombinant Human IL-2 (R&D Systems Cat# 202-IL-010/CF). Subsequently ...
-
bioRxiv - Bioengineering 2024Quote: ... PBMCs were stimulated for 2 days with anti-CD3/anti-CD28 T cell activation beads (Thermo, catalog no. 11131D) in the presence of interleukin-2 (IL-2; 40 IU/ml; R&D Systems, catalog no. 202-IL-010) in complete T cell media and incubated at 37°C ...
-
bioRxiv - Microbiology 2020Quote: ... cells were pre-treated with IL-4 (200 U/ml) (R&D Systems, Minneapolis, MN) for 12h at 37°C and then stimulated and infected as above ...
-
bioRxiv - Cell Biology 2021Quote: ... and 4 mg/ml Collagen-I (Cultrex 3D rat tail collagen-I, R&D systems) on ice ...
-
bioRxiv - Immunology 2023Quote: ... and 25ng/ml recombinant mouse IL-4 (clone 404-ML-025/CF; R&D System) in final volume of 200 μl of RPMI 1640 medium supplemented with 10% FBS ...
-
bioRxiv - Cell Biology 2024Quote: ... and 50 ng/mL bone morphogenetic protein 4 (BMP4; 314-BP, R&D Systems, USA) on day 1 ...
-
bioRxiv - Neuroscience 2022Quote: ... followed by 4 hour incubation with mouse anti-O4 IgM (1:1000; R&D Systems) and rat anti-MBP (1:500 ...
-
bioRxiv - Immunology 2023Quote: ... 2.5% HEPES and stimulated with 50ng/ml IL-4 (R&D Systems Cat: 404-ML) for 15 minutes at 37°C ...
-
bioRxiv - Developmental Biology 2023Quote: ... gfCDM media was supplemented with 5 nM BMP-4 (R&D Systems, #314-BP-050), followed by 1/2 media change on d9 and d12 ...
-
bioRxiv - Neuroscience 2023Quote: ... a 10 μL intramuscular injection of Spp1 neutralizing antibody (4 μg, AF808, R&D Systems) was administered into the tibialis anterior (TA ...
-
bioRxiv - Microbiology 2021Quote: ... cells were maintained in SFD media supplemented with the following: 3 μM CHIR 99021 (CHIR, R&D Systems), 10 ng/ml human FGF10 ...
-
bioRxiv - Cell Biology 2023Quote: ... after which the cells were exposed for 3 days to 200 ng/ml FGF-9 (R&D systems) and 1μg/mL heparin (Sigma Aldrich ...
-
bioRxiv - Developmental Biology 2024Quote: ... and incubated with rabbit active Caspase-3 (5 μg/ml, AF835-SP, R&D systems, Inc., Minneapolis, MN), rabbit cleaved Caspase-9 (1:50 ...
-
bioRxiv - Neuroscience 2023Quote: ... explants were incubated overnight in PBS 3% BSA with primary antibody: anti-Robo1 (R&D Systems, 1:400) or anti-Robo2 (gift from Dr Alain Chédotal 53 ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 100 U/mL rmIL-2 (402-ML-100, R&D Systems) in the presence of increasing concentrations of SU11652 (sc-204310 ...
-
bioRxiv - Cell Biology 2020Quote: ... PE anti-human ULBP-2/5/6 (Clone 165903, R&D Systems), FITC Mouse IgG1 κ Isotype Control (Clone MOPC-21 ...
-
bioRxiv - Immunology 2021Quote: ... and Rat IL-2 ELISpot Kit (R&D Systems, Cat. No.: XEL502). ELISpot plates precoated with capture antibody were blocked with LCM for at least 30 min at RT ...
-
bioRxiv - Neuroscience 2020Quote: ... 2 ng/ml Nrg1 (human NRG1-β1 extracellular domain, R&D Systems), and 2 μM forskolin ...
-
bioRxiv - Microbiology 2022Quote: ... and mouse anti-SARS-CoV-2 N monoclonal antibody (R&D systems, Clone 1035111 ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 5ng/ml IL-2(# 202-IL-050/CF, R&D Systems). Activated CD3+ T cells were isolated from Dynabead Mouse T Activator CD3/CD28 (#00775477 ...
-
bioRxiv - Bioengineering 2022Quote: ... and human fibroblast growth factor 2 (20 ng/mL, R&D Systems). hECSR was added to the bottom channel prior to addition of cells into the well ...
-
bioRxiv - Neuroscience 2020Quote: ... Recombinant human FGF-2 was purchased from R&D Systems (Minneapolis, MN).
-
bioRxiv - Cell Biology 2021Quote: ... or differentiated 10T1/2 cells were treated with LRG1 (R&D Systems) for 24 h and then treated with isoproterenol (Sigma ...
-
bioRxiv - Neuroscience 2021Quote: ... 2 mM L-glutamine and 20 ng/ml BDNF (R&D Systems). In each group (control and Celsr2 mutant) ...
-
bioRxiv - Cell Biology 2022Quote: ... 2) TGFβ2 (TGFβ2: 2.5 ng/ml; R&D Systems, Minneapolis, MN, USA) for 0-5 d followed by vehicle control (0.1% DMSO ...
-
bioRxiv - Immunology 2020Quote: ... or a combination of 2 µg/ml ICAM-1 (R&D Systems), 1 µg/ml NKp30 (R&D systems ...
-
bioRxiv - Bioengineering 2020Quote: ... Collagen gel loaded with BMP-2 (75 μg/mL, R&D Systems) was used as a positive control ...
-
bioRxiv - Molecular Biology 2021Quote: ... 0.5 ng/mL recombinant mouse IL-2(R&D system, MN, USA), and 50 μM β-mercaptoethanol (Sigma Aldrich ...
-
bioRxiv - Molecular Biology 2021Quote: ... 0.5 ng/mL recombinant mouse IL-2 (R&D system, MN, USA), and 50 μM β-mercaptoethanol (Sigma Aldrich ...
-
bioRxiv - Immunology 2020Quote: ... affinity-purified polyclonal α-human-Ace-2 antibody (R&D Systems #AF933), and recombinant human Ace-2 (R&D Systems #933-ZN-010 ...
-
bioRxiv - Immunology 2020Quote: ... Pen-Strep and human recombinant interleukin-2 (210U/mL, R&D systems). For activation ...
-
bioRxiv - Immunology 2021Quote: ... 2 nM of recombinant CHIT1 (R&D Systems. Cat # 3559-GH-010) was incubated with 20 μM substrate in McIlvain buffer (100 mM citric acid ...
-
bioRxiv - Immunology 2021Quote: ... and 5 ng/ml IL-2 (carrier-free; Tocris R&D Systems) added with cells ...
-
bioRxiv - Microbiology 2022Quote: ... and 2 ug/mL of MetAP enzyme (R&D Systems 3537-ZN). Product detection,each reaction well is supplemented with 25 uL of 2 ng/mL DPPIV/CD26 (serine exopeptidase diluted in activation buffer).
-
bioRxiv - Microbiology 2022Quote: ... LCN-2 levels were quantified later by ELISA (DY1851, R&D Systems).
-
bioRxiv - Neuroscience 2023Quote: ... and 20 ng/mL FGF-2 (R&D Systems, 233-FB-010). Media changes were performed every 48 hours and cells were allowed to proliferate ...
-
bioRxiv - Neuroscience 2023Quote: ... and 20 ng/mL FGF-2 (R&D Systems, 233-FB-010) on days 7 to 25 ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 µg/mL laminin (LM, R&D systems, 3400-010-02).
-
bioRxiv - Immunology 2022Quote: ... in the presence of IL-2 (100 U/ml, R&D Systems) and IL-7 (50 ng/ml ...
-
bioRxiv - Microbiology 2022Quote: ... and mouse anti-SARS-CoV-2 N monoclonal antibody (R&D systems, Clone 1035111 ...
-
bioRxiv - Cancer Biology 2024Quote: ... Serum Lipocalin-2 levels were measured by ELISA (DY1857, R&D Systems).
-
bioRxiv - Cancer Biology 2024Quote: ... 20 ng/ml EGF and 20ng/ml FGF-2 (R&D Systems). Cells were passaged regularly using Accutase (Stem Cell Technologies ...